NTM-1634

Investigated by: Alachua Government Services, Inc. · National Institute of Allergy and Infectious Diseases (NIAID)

today NCT03046550 · Ph 1

20172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT03046550	Mar → Oct 2017	—	Alachua Government Services, Inc.	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	NTM-1634	ClinicalTrials.gov intervention name — accepted as the source's own label NCT03046550 ↗
Route	Intravenous	“Administered intravenously” NCT03046550 ↗